Evaluating Trials of Adjuvant Therapy: Is There Benefit for People with Resected Renal Cancer?

Ian F. Tannock; Daniel A. Goldstein; Jonathan Ofer; Bishal Gyawali; Tomer Meirson

doi:10.1200/JCO.23.00280

Evaluating Trials of Adjuvant Therapy: Is There Benefit for People with Resected Renal Cancer?

Ian F. Tannock
, Daniel A. Goldstein
, Jonathan Ofer
, Bishal Gyawali
, Tomer Meirson

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Original language	English
Pages (from-to)	2713-2717
Number of pages	5
Journal	Journal of Clinical Oncology
Volume	41
Issue number	15
DOIs	https://doi.org/10.1200/JCO.23.00280
State	Published - 20 May 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.23.00280

Cite this

@article{be175c9b593e477fa1721694df157dbd,

title = "Evaluating Trials of Adjuvant Therapy: Is There Benefit for People with Resected Renal Cancer?",

author = "Tannock, \{Ian F.\} and Goldstein, \{Daniel A.\} and Jonathan Ofer and Bishal Gyawali and Tomer Meirson",

year = "2023",

month = may,

day = "20",

doi = "10.1200/JCO.23.00280",

language = "English",

volume = "41",

pages = "2713--2717",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "15",

}

TY - JOUR

T1 - Evaluating Trials of Adjuvant Therapy

T2 - Is There Benefit for People with Resected Renal Cancer?

AU - Tannock, Ian F.

AU - Goldstein, Daniel A.

AU - Ofer, Jonathan

AU - Gyawali, Bishal

AU - Meirson, Tomer

PY - 2023/5/20

Y1 - 2023/5/20

UR - https://www.scopus.com/pages/publications/85159762771

U2 - 10.1200/JCO.23.00280

DO - 10.1200/JCO.23.00280

M3 - Article

C2 - 36961983

AN - SCOPUS:85159762771

SN - 0732-183X

VL - 41

SP - 2713

EP - 2717

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

ER -

Evaluating Trials of Adjuvant Therapy: Is There Benefit for People with Resected Renal Cancer?

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this